NATIXIS ADVISORS, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,388
+16.2%
15,495
+10.4%
0.00%0.0%
Q2 2023$1,195
+10.8%
14,030
+7.6%
0.00%0.0%
Q1 2023$1,079
-99.9%
13,038
-16.3%
0.00%
-55.6%
Q1 2021$1,729,000
-20.5%
15,578
-15.0%
0.01%
-30.8%
Q4 2020$2,175,000
+31.5%
18,318
-3.4%
0.01%
+30.0%
Q3 2020$1,654,000
-31.9%
18,962
-30.0%
0.01%
-16.7%
Q2 2018$2,430,000
+31.1%
27,086
+6.9%
0.01%
-33.3%
Q1 2018$1,853,000
+24.2%
25,329
-1.4%
0.02%
+20.0%
Q4 2017$1,492,000
+31.6%
25,696
+1.7%
0.02%
+25.0%
Q3 2017$1,134,000
+28.1%
25,275
+12.7%
0.01%
+20.0%
Q2 2017$885,000
+86.7%
22,421
+71.1%
0.01%
+66.7%
Q3 2016$474,000
+35.4%
13,104
+8.6%
0.01%
+20.0%
Q2 2016$350,000
-3.3%
12,067
+16.7%
0.01%0.0%
Q1 2016$362,000
-87.9%
10,338
-85.7%
0.01%
-90.2%
Q2 2015$2,994,000
-33.1%
72,371
-27.4%
0.05%
-35.4%
Q1 2015$4,477,000
-34.2%
99,665
-45.2%
0.08%
-37.8%
Q4 2014$6,801,000
+27.6%
181,740
+19.1%
0.13%
+18.7%
Q3 2014$5,328,000
-38.4%
152,583
-37.7%
0.11%
-13.7%
Q2 2014$8,644,000
+3724.8%
245,025
+4457.8%
0.12%
+3000.0%
Q4 2013$226,000
+9.2%
5,376
+3.4%
0.00%0.0%
Q3 2013$207,000
-1.0%
5,199
+3.1%
0.00%0.0%
Q2 2013$209,0005,0420.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders